Manufacturer:Intra-Cellular Therapies, Inc
Usage: CAPLYTA is indicated for the treatment of schizophrenia in adults and for depressive episodes associated with bipolar I or II disorder in adults, used both as monotherapy and adjunctively with lithium or valproate.